We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
-9.29%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$24.7B
AUM Growth
-$9.98B
(-29%)
Cap. Flow
-$5.49B
Cap. Flow
% of AUM
-22.2%
Top 10 Holdings %
Top 10 Hldgs %
40.01%
Holding
122
New
16
Increased
31
Reduced
30
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$645M |
| 2 |
Amazon
AMZN
|
+$447M |
| 3 |
International Flavors & Fragrances
IFF
|
+$436M |
| 4 |
XP
XP
|
+$295M |
| 5 |
Otis Worldwide
OTIS
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$1.4B |
| 2 |
Humana
HUM
|
+$1.24B |
| 3 |
Twilio
TWLO
|
+$785M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$659M |
| 5 |
GE Aerospace
GE
|
+$501M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.58% |
| 2 | Financials | 20.43% |
| 3 | Industrials | 13.4% |
| 4 | Technology | 13.29% |
| 5 | Communication Services | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
UnitedHealth
UNH
$364B
| $39.2M | 0.16% |
+76,910
| New | +$37.1M |
|
|
OHPAU
77
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $37.2M | 0.15% |
3,788,774
+119,502
| +3% | +$1.18M |
|
78
Unum
UNM
$14.5B
| $35.8M | 0.14% |
+1,137,645
| New | +$31.8M |
|
|
TRML
79
DELISTED
Tourmaline Bio
TRML
| $32.4M | 0.13% |
328,962
| – | – |
|
80
Rallybio
RLYB
$88.8M
| $29.3M | 0.12% |
524,347
| – | – |
|
81
Edgewise Therapeutics
EWTX
$4.74B
| $26.5M | 0.11% |
2,727,249
| – | – |
|
|
OLPX
82
DELISTED
Olaplex Holdings
OLPX
| $25.2M | 0.1% |
1,613,189
| – | – |
|
83
PMV Pharmaceuticals
PMVP
$69.3M
| $22.4M | 0.09% |
1,076,000
-714,284
| -40% | -$12.6M |
|
|
KNTE
84
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $20.5M | 0.08% |
1,820,462
| – | – |
|
85
JPMorgan Chase
JPM
$971B
| $16.3M | 0.07% |
+119,706
| New | +$17.7M |
|
|
NUVL
86
DELISTED
Nuvalent
NUVL
| $15.4M | 0.06% |
1,110,170
-537,501
| -33% | -$7.81M |
|
|
DAWN
87
DELISTED
Day One Biopharmaceuticals
DAWN
| $11.5M | 0.05% |
1,157,424
| – | – |
|
|
LIAN
88
DELISTED
LianBio American Depositary Shares
LIAN
| $5.57M | 0.02% |
1,500,000
| – | – |
|
|
TDCX
89
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $1.72M | 0.01% |
141,117
-873,380
| -86% | -$12.3M |
|
90
VTEX
VTEX
$653M
| $187K | ﹤0.01% |
30,371
-2,992,909
| -99% | -$22.3M |
|
91
AdaptHealth
AHCO
$778M
| – | – |
-3,949,783
| Closed | -$96.6M |
|
92
American International
AIG
$39.9B
| – | – |
-2,903,295
| Closed | -$165M |
|
93
Assurant
AIZ
$13.9B
| – | – |
-1,723,771
| Closed | -$269M |
|
|
AMED
94
DELISTED
Amedisys
AMED
| – | – |
-391,131
| Closed | -$63.3M |
|
95
Apollo Global Management
APO
$82.2B
| – | – |
-538,212
| Closed | -$39M |
|
96
Bristol-Myers Squibb
BMY
$130B
| – | – |
-1,815,619
| Closed | -$113M |
|
97
FedEx
FDX
$77.2B
| – | – |
-655,242
| Closed | -$169M |
|
98
FIGS
FIGS
$2.38B
| – | – |
-14,742,689
| Closed | -$406M |
|
|
99
Humana
HUM
$46.3B
| – | – |
-2,663,368
| Closed | -$1.24B |
|
100
KKR & Co
KKR
$99.8B
| – | – |
-806,081
| Closed | -$60.1M |
|
Similar funds
VIA
Viking Global Investors's Q1 2022 Portfolio in Review
As of Q1 2022, Viking Global Investors held 122 positions worth $24.7B, down 29% from $34.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Viking Global Investors withdrew a net $5.49B in Q1 2022, closing 31 positions and reducing 30 holdings. Its most notable exit was Humana, an estimated $1.24B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 37% a quarter earlier, followed by Financials and Industrials.
Against the trend, Viking Global Investors opened a new position in Mastercard worth $641M.
- Viking Global Investors's largest Q1 2022 buy was Mastercard: 1,793,488 shares worth $641M.
- Viking Global Investors added most to Amazon in Q1 2022, an estimated $447M increase.
- Viking Global Investors's biggest Q1 2022 reduction was Ginkgo Bioworks, cutting an estimated $1.4B.
- Viking Global Investors fully exited Humana in Q1 2022, selling an estimated $1.24B.
- Viking Global Investors's ten largest holdings make up 40% of its $24.7B portfolio in Q1 2022.
- Viking Global Investors opened 16 new positions and closed 31 in Q1 2022.
- Viking Global Investors's portfolio value fell 29% quarter-over-quarter to $24.7B.
Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.